HilleVax (Crossover Financing)

Funding Details
Awarder
Inbox
Date Award
September 08, 2021
Vertical
Biopharmaceuticals
Funding URL
View Funding Page
Funding Amount:
$135,000,000

Company Info
Founders
Rob Hershberg
Company Description
HilleVax is a biopharmaceutical company that focuses on the development and commercialization of novel vaccines.
Market
Vaccine Development
Location
Boston, MA, USA
Coinvestors
Abingworth, BVF Partners, Catalys Pacific, Deerfield Management Company, L.P., Franklin Templeton, Frazier Healthcare Partners, Perceptive Advisors, Qiming Venture Partners, RA Capital Management, Samsara BioCapital

Links